Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia-Reference-Cited by-同舟云学术

Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia

Published:2023-05-25 Issue:8 Volume:102 Page:2039-2049
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Viprakasit Vip,Hamdy Mona M.,Hassab Hoda M. A.,Sherief Laila M.,Al-Bagshi Muneer,Khattab Mohammed,Chuncharunee Suporn,Dung Phu Chi,Küpesiz Alphan,Shekhawat Ankita,Sonawane Yamini,Perez Laura Torres,Slader Cassandra,Taher Ali T.^ORCID

Funder

Novartis Pharma AG

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05240-3.pdf

Reference20 articles.

1. Burkhart PV, Sabaté E (2003) Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 35:207

2. Trachtenberg FL, Gerstenberger E, Xu Y, Mednick L, Sobota A, Ware H, Thompson AA, Neufeld EJ, Thalassemia Clinical Research Network (2014) Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Qual Life Res 23(8):2277–2288. https://doi.org/10.1007/s11136-014-0671-2

3. Goldberg SL, Giardina PJ, Chirnomas D, Esposito J, Paley C, Vichinsky E (2013) The palatability and tolerability of deferasirox taken with different beverages or foods. Pediatr Blood Cancer 60(9):1507–1512. https://doi.org/10.1002/pbc.24561

4. Chat Chai AS, Draman N, Mohd Yusoff SS, Azman NF, Mohd Zulkifli M, Yaacob NM, Mohamad N, Hassan R, Abdullah WZ, Zilfalil BA (2021) Non-compliance to iron chelation therapy in patients with transfusion-dependent thalassaemia. Pediatr Hematol Oncol 6(4):207–215. https://doi.org/10.1016/j.phoj.2021.10.005

5. Chong CC, Redzuan AM, Sathar J, Makmor-Bakry M (2021) Patient perspective on iron chelation therapy: barriers and facilitators of medication adherence. J Patient Exp 8:2374373521996958. https://doi.org/10.1177/2374373521996958

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?;Pediatric Blood & Cancer;2024-05-16

2. Switching from Deferasirox Dispersible Tablets to Deferasirox Film-Coated Tablets: Is There an Effect on Ferritin Levels in Children and Adolescents with Transfusion-Dependent Anemia?;Turkish Archives of Pediatrics;2024-03-01

3. Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East;Blood Reviews;2024-01